Followers

0
0
0
0
.
6
6
0
0
5
5
,
1
1
9.70 (0.65%)

As on 26 Dec, 2025 | 15:59

Open Trading A/c
Day Range
1,494.00
1,510.90
LH
52 Week Range
1,335.00
1,673.00
LH
Volume
* i
Bid / Ask
951,555.00
0.00 / 0.00

Cipla Announcements

Cipla Limited has informed the exchange that it has entered into an exclusive Supply and Marketing Agreement for Pfizer s brands

19 Dec, 2025 | 11:37am • Source: NSE

Cipla Limited has informed the exchange that it has entered into an exclusive supply and marketing agreement with Pfizer''s brands

19 Dec, 2025 | 11:31am • Source: BSE

In compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that the Operations and Administrative Committee of the...

17 Dec, 2025 | 05:59pm • Source: BSE

Update on acquisition of securities in Inzpera Healthsciences Limited

04 Dec, 2025 | 10:24pm • Source: BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India

01 Dec, 2025 | 12:50pm • Source: BSE

Newspaper publication regarding special window for re- lodgement of transfer requests of physical shares

06 Nov, 2025 | 05:49pm • Source: BSE

We are enclosing hereby a copy of the transcript of the Company''s Q2 FY26 earning conference call dated 30th October, 2025.

03 Nov, 2025 | 04:37pm • Source: BSE

Acquisition of securities in Inzpera Healthsciences Limited

03 Nov, 2025 | 03:42pm • Source: BSE

Please find attached newspaper advertisement

31 Oct, 2025 | 12:17pm • Source: BSE

Pursuant to Regulation 30 read with Part A of Schedule III and Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the...

30 Oct, 2025 | 06:36pm • Source: BSE

Outcome of Board meeting dated 30th October, 2025

30 Oct, 2025 | 01:57pm • Source: BSE

Please find attached press release for Q2FY26

30 Oct, 2025 | 01:51pm • Source: BSE

Please find attached outcome of Board meeting

30 Oct, 2025 | 01:46pm • Source: BSE

Investor Presentation for Q2FY26 dated 30th October, 2025

30 Oct, 2025 | 01:08pm • Source: BSE

Please find attached financial results for the quarter and half year ended 30th September, 2025

30 Oct, 2025 | 12:57pm • Source: BSE

Please find attached financial results for the quarter and half year ended 30th September, 2025

30 Oct, 2025 | 12:50pm • Source: BSE

In compliance with provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that the Operations and Administrative Committee...

29 Oct, 2025 | 06:33pm • Source: BSE

Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018

19 Oct, 2025 | 03:51pm • Source: BSE